Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849491) titled 'Impact of Pharmacist Led Multidisciplinary Deprescribing Strategy in Patients With Respiratory Tract Infections' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
Primary Sponsor: Xi'an Jiaotong University
Condition:
Respiratory Tract Diseases
Intervention:
Drug: Pharmacist-Led Azithromycin Deprescribing Intervention
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 1, 2026
Target Sample Size: 200
Countries of Recruitment:
Pakistan
To know mor...